Comment by
wendhie05 on Dec 16, 2020 8:55am
This is how FSD Pharma doing it. The US Food and Drug Administration (FDA) has authorized the initiation of a Phase 2 study of FSD-201 on COVID-19 patients. The company plans to start oral dosing (tablets) more than 300 patients in October this year. The company completed a Phase 1 first-in-human safety and tolerability study for FSD201 in Australia.